Different subtypes were notable for particular molecular pathogenetic features; for example, EBV-positive tumours harboured recurrent PIK3CA mutations, along with amplifications involving JAK2, CD274 (encoding PD-L1) and PDCD1LG2 (encoding PD-L2). This evidence concerns the gene PDCD1LG2 and neoplasm.